CS logo
small CS logo
Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara

Guadalajara, Jalisco, Mexico
Research institute in Guadalajara
Sierra Mojada 950, Independencia Oriente, 44340 Guadalajara, Jal.

About Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara


During the past decade, Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 15 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 14 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara" #1 collaborator was "Hospital Civil de Guadalajara" with 3 trials as a collaborator, "Institute of Experimental and Clinical Therapeutics" with 1 trials as a collaborator, "Instituto Mexicano del Seguro Social" with 1 trials as a collaborator and "National Council of Science and Technology, Mexico" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara


According to Clinical.Site data, the most researched conditions in "Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara" are "Impaired Glucose Tolerance" (5 trials), "Metabolic Syndrome X" (5 trials), "Obesity" (4 trials), "Type 2 Diabetes Mellitus" (4 trials) and "Diabetes Mellitus, Type 2" (3 trials). Many other conditions were trialed in "Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara" in a lesser frequency.

Clinical Trials Intervention Types at Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara


Most popular intervention types in "Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara" are "Drug" (34 trials), "Dietary Supplement" (7 trials), "Other" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (22 trials), "Dapagliflozin" (5 trials), "Metformin" (4 trials), "Berberine" (2 trials) and "Combined antioxidant therapy" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara


The vast majority of trials in "Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara" are 38 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara


Currently, there are NaN active trials in "Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Experimental and Clinical Therapeutics (INTEC), CUCS, University of Guadalajara, 0 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 4 trials that are defined as “Not Applicable".